Dr. Ali Al-Ghamrawy, Chairman of the EDA, welcomed Dr. Ali Babiker, Secretary General of the Sudanese National Council for Medicines and Poisons, and the accompanying delegation. This meeting is part of the EDA's commitment to supporting and enhancing health and pharmaceutical cooperation with African nations.

At the start of the meeting, Dr. Al-Ghamrawy welcomed the Sudanese delegation, expressing his pride in the historical relations between the two nations. He affirmed the EDA's keenness to expand areas of cooperation in pharmaceutical regulation, which contributes to enhancing national capacities and achieving shared pharmaceutical security. He explained that the National Council for Medicines and Poisons is a crucial strategic partner on the African stage, especially given the shared challenges in ensuring the availability of safe, effective, and high-quality medicines, which supports the path toward regional integration.

Al-Ghamrawy also noted that the EDA prioritizes supporting sister African countries with its regulatory and technical expertise, and working to exchange knowledge and successful experiences, which contributes to the development of systems for pharmaceutical registration, manufacturing, and control, and ultimately achieves the goals of sustainable health security on the continent.

For his part, Dr. Ali Babiker expressed his appreciation for the warm reception, commending the qualitative achievements made by the Egyptian Drug Authority that have reinforced its position as a regional reference center in the field of pharmaceutical regulation and industry. He affirmed his aspiration to expand cooperation with Egypt to develop Sudan's health and pharmaceutical system, and open new horizons for pharmaceutical integration between the two countries and all other African states.

The meeting was attended from the EDA's side by:

· Dr. Osama Hatem, Associate to the EDA Chairman for Policy and International Cooperation and Supervisor of the Central Administration of Pharmaceutical Policies and Market Access.

· Dr. Mohab Fady, Head of the Central Administration for Licensing of Pharmaceutical Establishments

· Dr. Hamada Gamal, Associate to the Chairman for Updating and Developing Registration Systems for pharmaceutical Products and General Manager of General Administration for Human Pharmaceutical Registration.

From the Sudanese side, the attendees included:

· Dr. Noon Jar Al-Nabi Babiker, Assistant of Secretary - General

· Dr. Wejdan Khalid Muhammad Al-Feel, Secretary of Planning and Policies Secretariat and Manager of the council Office in Cairo

· Dr. Manhal Sayed Ahmed Abu Zeid, Secretary of the Registration Secretariat

· Dr. Huda Muhammad Al-Mukhtar Al-Amin, Deputy Secretary of the National Manufacturing Secretariat

· Dr. Inas Omar Muhammad, Manager of Licensing

This visit is framed by the historical relations and fraternal ties that unite the Egyptian and Sudanese peoples and reflects the commitment of both countries to enhancing cooperation in the health and pharmaceutical sector, thereby promoting sustainable health security and supporting the development process in the African continent.